The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone

Mini Rev Med Chem. 2009 Aug;9(9):1052-63. doi: 10.2174/138955709788922683.

Abstract

Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, deformity and other complications leading to significant disability and bone pain. Recently, the availability of newer, more potent nitrogen-containing bisphosphonates has improved treatment outcomes, allowing a more effective and convenient management of this disorder.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / chemistry
  • Bone Density Conservation Agents / therapeutic use*
  • Diphosphonates / administration & dosage*
  • Diphosphonates / chemistry
  • Diphosphonates / therapeutic use*
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / chemistry
  • Imidazoles / therapeutic use
  • Injections, Intravenous
  • Osteitis Deformans / drug therapy*
  • Pamidronate
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
  • 6-amino-1-hydroxyhexane-1,1-diphosphonate
  • Pamidronate